Qixue K. Wang

Key Laboratory Of Post Neuro Injury Neuro Repair And Regeneration In Central Nervous System
Tianjin, 300052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Journal: Cancer letters
Published: January 29, 2026

Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation.

Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 08, 2025

NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu²+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis).

NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu²+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis).

Journal: Neuro-oncology
Published: August 30, 2025

LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastoma.

LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastoma.

Journal: Theranostics
Published: July 29, 2025

VITA-GBM: EPIC-0502-driven HIF1α degradation overcomes bevacizumab resistance and synergizes with TMZ in glioblastoma.

VITA-GBM: EPIC-0502-driven HIF1α degradation overcomes bevacizumab resistance and synergizes with TMZ in glioblastoma.

Journal: Neuro-oncology
Published: July 02, 2025

PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization.

PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization.

Journal: Neuro-oncology
Published: May 14, 2025

EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy.

EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy.

Journal: Free radical biology & medicine
Published: January 09, 2025

ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway.

ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway.

Journal: Cancer letters
Published: October 05, 2024

CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio.

CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 20, 2024

Epigenetically elevated RAD51AP1 regulates the RAD51-UAF1 complex contributing to temozolomide resistance in EGFRvIII glioblastoma.

Epigenetically elevated RAD51AP1 regulates the RAD51-UAF1 complex contributing to temozolomide resistance in EGFRvIII glioblastoma.

Journal: Chinese medical journal
Published: August 13, 2024

Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma.

Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma.

Journal: Acta pharmaceutica Sinica. B
Published: June 26, 2024

Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.

Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 03, 2024
Showing 1-12 of 82

Last Updated: 09/26/2026